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DObjective: The SYNergy between percutaneous intervention with TAXus drug eluting stents and cardiac
surgery (SYNTAX) Score is a tool for risk stratification of patients according to the complexity of coronary
lesions developed during the SYNTAX trial. We examined the influence of the SYNTAX Score on the incidence
of major adverse cardiac and cerebrovascular events.
Methods: All patients with de novo left main or 3-vessel disease undergoing coronary artery bypass grafting
from January 2005 to December 2008 at our institution (Hospital Clınico San Carlos, Madrid, Spain) were ret-
rospectively assessed, and their SYNTAX Score was calculated. The influence of the SYNTAX Score on post-
procedural and follow-up mortality and combined major adverse cardiac and cerebrovascular events (including
death, myocardial infarction, cerebrovascular accident, and repeat revascularization) was identified by multivar-
iate analysis. Balancing score analysis was performed to eliminate the effect of potential confounders.
Results: A total of 716 patients were enrolled. Mean SYNTAX Score was 34.5 (standard deviation, 6.7;
range, 11.5–76). Three groups of patients were identified according to the score terciles: low (33), intermediate
(33–37), and high (>37). These terciles scores differed greatly from those reported by the SYNTAX trial inves-
tigators. The multivariate analysis identified that the SYNTAX Score was associated with follow-up mortality
(hazard ratio ¼ 1.046, P ¼ .015) and combined early and follow-up major adverse cardiac and cerebrovascular
events (odds ratio¼ 1.079, P<.001; and hazard ratio¼ 1.034, P¼ .026, respectively). Balancing score-adjusted
analyses demonstrated that the SYNTAX Score was independently associated with early and late major adverse
cardiac and cerebrovascular events (odds ratio ¼ 1.65, P<.001; and hazard ratio ¼ 1.034, P ¼ .027, respec-
tively).
Conclusions: SYNTAX Score was remarkably high among patients undergoing surgical off-pump myocardial
revascularization at our institution. In this subset of patients, a higher SYNTAX Score was associated with
a higher incidence of in-hospital and follow-up major adverse cardiac and cerebrovascular events after coronary
artery bypass grafting, but not with early or late mortality. (J Thorac Cardiovasc Surg 2011;142:e123-32)Coronary artery bypass grafting (CABG) surgery is cur-
rently the treatment of choice for 3-vessel and left main
coronary artery (LMCA) disease.1,2 However, recent
developments in percutaneous coronary intervention (PCI)
have made its endovascular treatment feasible.3,4 CABG
has also undergone advances, such as less invasive
surgical access, use of arterial rather than venous grafts,
and off-pump surgery.5 To reassess and compare the out-
comes of both therapeutic options, the SYNergy betweene Departments of Cardiac Surgerya and Epidemiology and Public Health,b
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The Journal of Thoracic and Carpercutaneous intervention with TAXus drug eluting stents
and cardiac surgery (SYNTAX) trial was initiated in
2005.6 In this randomized multicenter trial, the outcomes
of PCI using paclitaxel-eluting TAXUS stents and CABG
for the treatment of 3-vessel and LMCA disease were com-
pared. The SYNTAX Score is a comprehensive angio-
graphic scoring system that assesses coronary lesion
complexity within the context of this trial to select patients
for one or the other option.7 In addition to showing accept-
able reproducibility, the Syntax score has shown good
predictive behavior. Thus, in a report of postprocedural
and 1-year outcomes of surgical or PCI revascularization
in the patients initially included in the SYNTAX trial strat-
ified by SYNTAX Score, a lower major adverse cardiac and
cerebrovascular events (MACCE)-free survival was re-
corded for the patients with the higher scores in the PCI
group.8 On the other hand, Mohr and colleagues9 assessed
the prognostic value of the SYNTAX Score in the SYNTAX
trial CABG group and found no relationship between thediovascular Surgery c Volume 142, Number 3 e123
Abbreviations and Acronyms
AMI ¼ acute myocardial infarction
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CK ¼ creatine kinase
COPD ¼ chronic obstructive pulmonary
disorder
CPB ¼ cardiopulmonary bypass
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
HR ¼ hazard ratio
IQR ¼ interquartile range
LMCA ¼ left main coronary artery
MACCE ¼ major adverse cardiac and
cerebrovascular events
OR ¼ odds ratio
PCI ¼ percutaneous coronary
intervention
SD ¼ standard deviation
SYNTAX ¼ SYNergy between percutaneous
intervention with TAXus drug
eluting stents and cardiac surgery
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the score has been also studied in cohorts of patients differ-
ent from those of the SYNTAX study undergoing PCI10-12
and surgical revascularization for LMCA disease13 or
3-vessel disease.14 The present study was designed to assess
the use of the SYNTAX Score to predict MACCE in the
postprocedural course of patients undergoing CABG with
de novo 3-vessel or LMCA disease.MATERIALS AND METHODS
Patients
All patients undergoing isolated CABG between January 2005 and
December 2008 at the Hospital Clınico San Carlos (Madrid, Spain) were
retrospectively assessed. Patients were enrolled if they had de novo 3-ves-
sel, isolated LMCA, or LMCA disease with 1, 2, or 3 coronary vessels re-
quiring surgical revascularization. Patients were excluded if they had
undergone prior revascularization or single or 2-vessel disease. These cri-
teria were similar to those of the original design of the SYNTAX trial.6 Be-
fore surgical intervention, written informed consent was obtained from all
patients. The study protocol was approved by the institutional review board
of our institution. Demographic, anthropometric, clinical, and surgical data
were obtained from each patient. Postprocedural risk was estimated using
the European System for Cardiac Operative Risk Evaluation (euro-
SCORE).15 A list of all analyzed variables is provided in Table 1. The
follow-up was completed between April 2009 and June 2009. For this pur-
pose, patients were contacted by telephone calls or office visits during this
period of time.
Coronary Artery Bypass Grafting Technique
Off-pump CABG surgery was always the first choice. Cardiopulmonary
bypass (CPB) was conducted only in patients who showed hemodynamice124 The Journal of Thoracic and Cardiovascular Suror electric instability that could not be corrected otherwise during surgery.
Internal thoracic artery, saphenous vein, or radial artery grafts were
harvested. Heparin was administered to achieve an activated clotting
time of 300 to 350 seconds. First, the area of the anterior descending artery
was revascularized. Next, distal anastomoses to the lateral, posterolateral,
and diaphragmatic aspects were undertaken. Finally, proximal aspects were
anastomosed to the ascending aorta with side clamping. Anastomoses were
achieved by running suture, using a non-reabsorbable 7-0 monofilament
(6-0 for sutures to the aorta). The heparin effect was reversed using
protamine.
SYNTAX Score
By using the criteria of the SYNTAX trial,7 we assessed all stenoses
50% or greater in any coronary vessel with a diameter of 1.5 mm or greater.
For each patient, the score was retrospectively calculated by a single team
comprising a heart surgeon and an interventional cardiologist (not blindly).
The last coronary angiography before CABG procedure was used for score
assessment. The SYNTAXScorewas divided into 3 terciles according to its
distribution in the population of patients included in the study.
Objective
The main aim of this study was to examine the effect of the SYNTAX
Score on the outcomes of CABG for 3-vessel or left main disease. We re-
corded the incidence of the followingmajor events during the postprocedural
course (defined as the patient’s hospital stay or the 30 days after surgery) and
in the follow-up: (1) all cause death; (2) grouped MACCE, including (a)
death; (b) acutemyocardial infarction (AMI) (troponin I>15mg/L in the first
12 hours, troponin I>20 mg/L in the first 24 hours or creatine kinase [CK]-
MB5 times greater than the upper limit of the normal range after CABG; CK
to CK-MB value 5 times the upper limit of normal in the follow-up);6,16 (c)
permanent stroke (focal neurologic defect> 24 hours causing irreversible
brain damage or permanent disability);6 and (d) repeat revascularization
(PCI or CABG). Only first event survival was assessed in the follow-up.
Thus, repeated events were discarded.
Statistical Analysis
Continuous variables were compared with linear regression. Differ-
ences between qualitative variables were assessed using the chi-square
test (linear trend if independent variable was ordinal) or Fisher’s exact
test (for expected frequencies<5). Student t test, Mann–Whitney U test,
or analysis of variance was used to compare quantitative (dependent) ver-
sus qualitative (independent) variables depending on normality and number
of categories.
Potential confounding factors associated with the SYNTAX Score were
identified using simple linear regression. Then, a balancing score17 was de-
veloped using non-parsimonious multiple linear regression models that in-
cluded those variables associated with the SYNTAX Score (P<.10) and
first order interactions. The highest R2 model was selected to develop the
balancing score.
Risk factors for postprocedural events were identified by univariate and
multivariate analyses. We performed a non-balanced binary logistic regres-
sion analysis including all variables found to be associated with postproce-
dural events in the univariate analysis (P<.20) and those associated with
the SYNTAXScore (P<.05). The balancing scorewas included in the mul-
tivariate analysis to better discriminate potential confounders.
Event-free survival in the follow-up was assessed including both post-
procedural and postdischarge events. Follow-up survival curves were pro-
duced according to the Kaplan–Meier method. Mantel–Haenszel log-rank
tests were performed to analyze survival differences. Independent predic-
tive factors for outcomes during the follow-up period were detected using
a Cox proportional hazard model. Variables included in multivariate Cox
model were those associated with the SYNTAX Score (P<.05) and those
linked to the incidence of events in a univariate Coxmodel (P<.20). Again,
to avoid further bias, the balancing score was included in the Cox analysis.gery c September 2011
TABLE 1. Baseline characteristics by SYNTAX Score terciles and SYNTAX Score by number of disease vessels
SYNTAX Score and baseline characteristics
SYNTAX Score 33; n ¼ 282 33–37; n ¼ 219 >37; n ¼ 215 P
Female gender 74 (26.3%) 45 (20.5%) 31 (14.4%) .001
Age, y 65.16 (10.9) 68.49 (9.28) 69.51 (9.28) <.001
Obesity (BMI>30 kg/m2) 69 (24.5%) 57 (26%) 34 (15.8%) .030
Diabetes 78 (28%) 106 (48.4%) 132 (62%) <.001
Arterial hypertension 175 (62.5%) 164 (74.9%) 163 (75.8%) .001
Dyslipidemia 179 (64.6%) 154 (70.6%) 150 (70.1%) .176
PVD 27 (9.6%) 40 (18.3%) 80 (37.2%) <.001
Smoker 153 (54.8%) 119 (54.8%) 120 (56.1%) .793
COPD 20 (7.1%) 31 (14.2%) 22 (10.3%) .186
Prior stroke 6 (2.1%) 17 (7.8%) 23 (10.8%) <.001
Chronic renal failure 18 (6.4%) 23 (10.5%) 45 (20.9%) <.001
Previous AMI 131 (46.5%) 109 (49.8%) 115 (53.5%) .120
AMI<90 d 92 (32.6%) 77 (35.2%) 72 (33.5%) .808
LVEF<60% 61 (21.6%) 53 (24.2%) 67 (31.2%) .017
Severe PHT* 7 (2.5%) 10 (4.6%) 8 (3.7%) .416
NYHA III/IV 82 (29.1%) 75 (34.2%) 91 (42.4%) <.001
Reoperation 7 (2.5%) 7 (3.2%) 12 (5.6%) .073
Critical preprocedural statey 46 (16.4%) 28 (12.8%) 36 (16.7%) .985
Incomplete revascularization 32 (11.4%) 50 (22.8%) 46 (21.4%) <.001
Saphenous graft 152 (54.1%) 149 (68%) 141 (65.6%) .006
ITA graft 280 (99.6%) 216 (98.6%) 213 (99.1%) .442
Bilateral ITA graft 76 (27%) 29 (13.2%) 40 (18.6%) .011
Radial artery graft 39 (13.9%) 23 (10.5%) 20 (9.3%) .105
Endarterectomy 15 (5.3%) 10 (4.6%) 16 (7.4%) .353
Conversion to CPB 9 (3.2%) 9 (4.1%) 9 (4.2%) .399
euroSCORE 4 (IQR 2–6) 5 (IQR 3–7) 5 (IQR 3–8) <.001
euroSCORE logistic 5 (SD 4.3) 5.7 (SD 3.9) 7.7 (4.9) .009
SYNTAX Score and coronary anatomy
SYNTAX Score 33; n ¼ 282 33–37; n ¼ 219 >37; n ¼ 215 P
Main coronary artery lesion 153 (54.4%) 24 (11%) 142 (66.4%) .085
No. affected vessels <.001
0 vessels 13 (4.6%) 0 (0%) 0 (0%)
1 vessel 41 (14.6%) 0 (0%) 0 (0%)
2 vessels 93 (33.1%) 17 (7.8%) 3 (1.4%)
3 vessels 134 (47.7%) 202 (92.2%) 212 (98.6%)
No. of diseased vessels n (%) SYNTAX Score P
Left main plus 0 vessel 15 (2.1%) 17.5 (IQR 16.8–20.3) <.001
Left main plus 1 vessel 51 (5.7%) 23.5 (IQR 22.5–25.5)
Left main plus 2 vessels 113 (15.8%) 30.5 (IQR 28.5–32.5)
Left main plus 3 vessels 152 (21.2%) 41 (IQR 39.5–43.5)
3-vessel disease (no left main) 395 (55.2%) 34.5 (IQR 33–37)
Data expressed as absolute frequencies (n) and percentages (%) or means and SD (or medians and IQR). Only data for valid cases are provided; lost cases were not assessed. Chi-
square or Fisher’s exact test (depending on the expected frequency) was used to compare qualitative variables. Analysis of variance used to compare means. CAD,Coronary artery
disease; AMI, acute myocardial infarction; BMI, body mass index; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejec-
tion fraction;NYHA,NewYork Heart Association; ITA, internal thoracic artery;CPB, cardiopulmonary bypass; PHT, pulmonary hypertension; euroSCORE, European System for
Cardiac Operative Risk Evaluation; SYNTAX, SYNergy between percutaneous intervention with TAXus drug-eluting stents and cardiac surgery. *Considered only if severe: pul-
monary artery systolic pressure>60 mm Hg. yCritical preprocedural state: ventricular tachycardia, ventricular fibrillation or aborted sudden death, cardiac massage, invasive
ventilatory support, need for inotropic support or balloon counterpulsation, acute renal failure (anuria or oliguria<10 mL/h).
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TABLE 2. Early outcome frequencies
SYNTAX Score 33; n ¼ 282 33–37; n ¼ 219 >37; n ¼ 215 P
Postprocedural mortality 10 (3.6%) 7 (3.2%) 19 (8.8%) .011
Postprocedural stroke 2 (0.7%) 2 (0.9%) 4 (1.9%) .240
Periprocedural AMI 12 (4.3%) 43 (19.6%) 42 (19.5%) <.001
Early repeat revascularization 6 (2.1%) 6 (2.7%) 6 (2.8%) .632
Grouped MACCE 22 (7.8%) 50 (22.8%) 50 (23.3%) <.001
Data expressed as absolute frequencies (n) and percentages (%). Chi-square (lineal trend) or Fisher’s exact test depending on the expected frequency was used to compare qual-
itative variables. AMI, Acute myocardial infarction; MACCE, major adverse cardiac and cerebrovascular events; SYNTAX, SYNergy between percutaneous intervention with
TAXus drug-eluting stents and cardiac surgery.
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variables and multivariate models residuals. PASW 18.0 for Windows
(SPSS Inc, Chicago, Ill) was used for statistical analysis.
RESULTS
Baseline Clinical Characteristics
From January 2005 to December 2008, 920 patients con-
secutively underwent isolated CABG surgery. Of these, 716
patients were enrolled in this study and 204 patients were
excluded for the following reasons: 2-vessel disease
(n¼ 137), single-vessel disease (n¼ 44), or previous revas-
cularization (n ¼ 134).
Clinical and anatomic baseline characteristics by
SYNTAX Score terciles are shown in Table 1. These data
indicate a significantly older age in the 2 groups with
higher scores and a greater prevalence of women in the first
2 score groups. Among the cardiovascular risk factors ex-
amined, a higher prevalence of diabetes mellitus, arterial
hypertension, peripheral vascular disease, chronic kidney
disease, and prior stroke were observed in the top 2 SYN-
TAX Score groups. A higher prevalence of patients in func-
tional class III or IV was also observed in the 2 higher score
terciles.
Revascularization procedure details are also shown in
Table 1. Mean mortality predicted by logistic regression
of the euroSCORE was 6.1% (standard deviation [SD],
4.3). A total of 110 patients (15.4%) underwent CABG in
a critical preprocedural state (according to the euroSCORE
definition14). In 27 patients (3.8%), the procedure was
converted on-pump. A total of 548 patients (76.5%) had
3-vessel disease, and 319 patients (44.6%) had LMCA
disease. Some 709 of the patients (99%) received at least
1 internal thoracic artery, 442 patients (61.7%) received
at least 1 saphenous vein, and 82 patients (11.4%) received
at least 1 radial artery graft. More incomplete revasculariza-
tions were observed in the 2 top score groups (P<.001).
When the standard euroSCORE was compared with the
SYNTAX Score, a positive linear correlation was observed
(b¼ 0.152 euroSCORE points/SYNTAX Score point, 95%
confidence interval [CI], 0.064–0.240; P ¼ .001).
Coronary artery disease characteristics are shown in
Table 1. The mean SYNTAX Score was 34.5 (SD, 6.7;
range, 11.5–76). As expected, higher SYNTAX Scores
were observed among patients with 3-vessel disease (me-e126 The Journal of Thoracic and Cardiovascular Surdian 34.5, interquartile range [IQR], 33–37) and LMCA
plus 3-vessel (median, 41; IQR, 39.5–43.5). The prevalence
of 3-vessel disease was greater in the 2 top score groups
(P< .01), whereas the prevalence of LMCA disease was
greater in the lowest and highest SYNTAX Score groups
(P<.085).
A balancing score was produced using multiple linear
regression including those factors associated with the
SYNTAX Score (P<.10) and their first order interactions.
The highest R2 model was selected among those obtained.
This score included age, obesity, diabetes, high blood pres-
sure, peripheral vascular disease, previous cerebrovascular
accident, chronic renal failure, left ventricle ejection frac-
tion less than 50%, incomplete revascularization, saphe-
nous vein grafting, bilateral internal thoracic artery
grafting, New York Heart Association III/IV, gender, and
first order interactions for gender, age, obesity, diabetes
mellitus, high blood pressure, incomplete revascularization,
and peripheral vascular disease.Postprocedural Events
Ninety-seven patients (13.5%) had an AMI, 8 patients
(1.1%) had a stroke, 18 patients (2.5%) required a repeat
revascularization, and 36 patients (5%) died in the postop-
erative course. A total of 122 patients (17.0%) had at least 1
adverse event. Table 2 shows the incidence of events by
SYNTAX Score terciles.
Univariate binary logistic regression analysis was per-
formed to detect those dependent variables related to the
studied events (P<.20) (Table 3) to be included in the mul-
tivariate analysis. In the multivariate binary logistic regres-
sion (Table 3), female gender, age, chronic obstructive
pulmonary disorder (COPD), NYHA III/IV class, critical
preprocedural state, coronary endarterectomy, and conver-
sion to CPB were independent predictors for in-hospital
mortality. The SYNTAX Score was not associated with
a higher in-hospital mortality (odds ratio [OR] ¼ 1.049,
95% CI, 0.995–1.106; P ¼ .077). After performing the
same multivariate analysis adjusted by the balancing score,
the SYNTAX Score was not associated with postprocedural
mortality (OR ¼ 1.039; 95% CI, 0.977–1.105; P ¼ .223).
Female gender, diabetes mellitus, critical preprocedural
state, coronary endarterectomy, conversion to CPB, andgery c September 2011
TABLE 3. Univariate and multivariate logistic regression analyses of early events
Postoperative mortality Postoperative combined MACCE
Univariate analyses Multivariate analyses Univariate analyses Multivariate analyses
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Female gender 2.541 (1.267–5.096) .009 2.924 (1.306– 6.545) .009 1.45 (0.923–2.278) .106 1.974 (1.198–3.252) .008
Age (y) 1.087 (1.041–1.135) <.001 1.059 (1.011–1.11) .016 1.032 (1.011–1.054) .003 1.016 (0.989–1.043) .251
BMI  30 kg/m2 0.640 (0.351–1.902) .640 0.793 (0.298–2.107) .641 0.631 (0.377–1.057) .08 0.605 (0.35–1.046) .072
Diabetes mellitus 1.617 (0.824–3.176 .162 1.156 (0.519–2.576) .722 0.822 (0.553–1.222) .333 0.593 (0.379–0.926) .022
High blood pressure 2.193 (0.899–5.348) .084 1.141 (0.402–3.241) .804 1.71 (1.072–2.726) .024 1.537 (0.929–2.543) .094
Dyslipidemia 1.428 (0.66–3.088) .366 — — 1.127 (0.736–1.726) .582 — —
Peripheral vascular disease 2.612 (1.302–5.242) .007 1.368 (0.566–3.306) .486 1.189 (0.745–1.897) .468 0.898 (0.522–1.545) .698
Smoker 0.634 (0.323–1.245) .186 0.781 (0.291–1.47) .45 0.689 (0.465–1.021) .063 0.981 (0.45–3.211) .687
COPD 3.203 (1.443–7.108) .004 3.5 (1.413–8.673) .007 1.061 (0.563–2.001) .584 1.13 (0.558–2.285) .734
Previous stroke 1.334 (0.393–4.526) .644 0.733 (0.186–2.881) .656 0.716 (0.297–1.729) .458 0.574 (0.223–1.478) .574
Chronic renal failure 2.201 (0.969–5) .059 1.225 (0.441–3.406) .697 1.232 (0.696–2.18) .474 0.573 (0.222–1.474) .248
Previous AMI 0.903 (0.461–1.767) .765 — — 0.981 (0.664–1.448) .923 — —
Recent AMI 0.859 (0.415–1.777) .682 — — 1.042 (0.691–1.571) .844 — —
LVEF<50% 1.716 (0.85–3.462) .132 0.852 (0.332–2.184) .738 1.128 (0.725–1.753) .594 0.945 (0.56–1.596) .833
Severe pulmonary
hypertension*
5.315 (1.871–15.097) .002 2.376 (0.606–9.321) .214 1.965 (0.802–4.813) .139 1.522 (0.546–4.238) .422
NYHA III/IV 4.062 (1.995–8.273) <.001 2.869 (1.327–6.2) .007 1.322 (0.893–1.988) .160 1.061 (0.669–1.685) .8
Previous cardiac surgery 2.593 (0.741–9.076) .136 1.468 (0.322–6.694) .62 3.825 (1.712–8.548) .001 2.414 (0.989–5.895) .053
Critical preprocedural statey 4.391 (2.187–8.817) <.001 2.909 (1.352–6.258) .006 2.245 (1.401–3.599) .001 2.151 (1.301–3.556) .003
Incomplete revascularization 1.21 (0.613– 2.388) .583 0.776 (0.339–1.777) .548 0.992 (0.67–1.469) .969 0.759 (0.478–1.206) .244
Saphenous grafts 0.969 (0.487–1.928) .929 0.525 (0.220–1.25) .145 1.307 (0.865–1.975) .204 0.93 (0.543–1.59) .79
Radial artery graft 1.261 (0.476–3.339) .641 — — 0.824 (0.432–1.573) .557 — —
ITA graft 0.26 (0.03–2.283) .224 — — 0.2 (0.04–1.001) .05 0.229 (0.044–1.2) .081
Bilateral ITA graft 0.621 (0.237–1.626) .332 0.587 (0.201– 2.56) .901 0.692 (0.408–1.173) .171 0.97 (0.471–1.995) .933
Coronary endarterectomy 2.881 (1.057–7.85) .039 3.125 (1.016–9.677) .047 2.748 (1.395–5.411) .003 2.76 (1.328–5.738) .007
Conversion to CPB 3.322 (1.381–7.992) .007 4.762 (1.648–13.762) .004 3.366 (1.858–6.1) <.001 2.752 (1.44–5.261) .002
SYNTAX Score 1.053 (1.007–1.102) .023 1.049 (0.995–1.106) .077 1.06 (1.029–1.092) <.001 1.079 (1.042–1.118) <.001
Data expressed as OR, 95% CI, and P value. Binary logistic regression was performed for univariate and multivariate analyses. Variables to be included in multivariate analysis:
univariate analysis (P<.2) and those associated with SYNTAX Score (P<.05). AMI, Acute myocardial infarction;MACCE, major adverse cardiac and cerebrovascular events.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; ITA, internal thoracic artery; CPB, cardiopulmonary bypass;
NYHA,New York Heart Association; SYNTAX, SYNergy between percutaneous intervention with TAXus drug-eluting stents and cardiac surgery. *Pulmonary hypertension con-
sidered only if severe: pulmonary artery systolic pressure>60 mm Hg. yCritical preprocedural state: ventricular tachycardia, ventricular fibrillation or aborted sudden death,
cardiac massage, invasive ventilatory support, need for inotropic support or balloon counterpulsation, acute renal failure (anuria or oliguria<10 mL/h).
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in a multivariate binary logistic regression. Once adjusted by
the balancing score, the SYNTAX Score remained indepen-
dently associated with a higher risk of postprocedural
MACCE (OR ¼ 1.065, 95% CI, 1.03–1.1; P<.001).
Follow-up
One patient was lost to follow-up. Median follow-up was
26.68 months (IQR, 10.97–39.52).
Survival at 1, 2, and 4 years for each SYNTAX Score ter-
cile was as follows: low score (33): 95%, 93%, and 92%,
respectively; medium (33–37): 91%, 91%, 82%, respec-
tively; and high (>37): 87%, 85%, 73%, respectively.
Log-rank tests for each period demonstrated statistically
significant differences (P ¼ .015, P ¼ .009, and P ¼ .032,
respectively) (Figure 1, A). Survival free from combined
MACCE for each tercile were as follows: low score
(33): 91%, 86%, and 79%, respectively; medium
(33–37): 85%, 81%, 54%, respectively; and high (>37):The Journal of Thoracic and Car79%, 78%, and 67%, respectively. Again, log-rank tests
for each period demonstrated statistically significant sur-
vival differences (P¼ .011, P<.001, and P¼ .009, respec-
tively) (Figure 1, B). Figure 1, C–E shows survival curves
for AMI, acute cerebrovascular accident, and repeat
revascularization. Survival differences were statistically
significant when comparing survival free from AMI
(Mantel–Haenszel log-rank test P¼ .001), but not for acute
cerebrovascular accident or repeat revascularization
(P ¼ .582 and P ¼ .289, respectively).
Table 4 shows the univariate and unadjusted multivariate
Cox analysis for mortality and incidence of MACCE in the
follow-up. Age, female gender, COPD, pulmonary systolic
pressure greater than 60 mm Hg, NYHA III/IV, critical pre-
procedural state, conversion to CPB, and SYNTAX Score
were associated with a worse survival in the follow-up.
When adjusting the multivariate Cox analysis with the bal-
ancing score, SYNTAX Score was no longer associated
with a higher follow-up mortality (hazard ratio [HR],diovascular Surgery c Volume 142, Number 3 e127
FIGURE 1. Survival curves for follow-up MACCE. A, Survival. B, Survival free from MACCE. C, Survival free from AMI. D, Survival free from acute
cerebrovascular accident. E, Survival free from repeat revascularization. Mantel–Haenszel log-rank tests. Statistically significant differences: P< .05.
SYNTAX, SYNergy between percutaneous intervention with TAXus drug eluting stents and cardiac surgery.
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TABLE 4. Univariate and multivariate Cox proportional hazard models of follow-up events
Mortality Combined MACCE
Univariate analyses Multivariate analyses Univariate analyses Multivariate analyses
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Age (y) 1.078 (1.046–1.112) <.001 1.058 (1.024–1.093) .001 1.033 (1.013–1.053) .001 1.019 (0.998–1.041) .076
Female gender 2.253 (1.352–3.756) .002 2.301 (1.311– 4.039) .004 1.531 (1.025–2.287) .038 1.583 (1.02–2.457) .041
BMI  30 kg/m2 0.879 (0.478–1.616) .677 1.03 (0.521–2.035) .933 0.974 (0.63–1.505) .905 1.003 (0.628–1.601) .992
Diabetes mellitus 1.421 (0.87–2.321) .161 1.05 (0.602–1.83) .864 1.484 (1.035–2.128) .032 1.302 (0.88–1.925) .187
High blood pressure 1.645 (0.894–3.025) .109 0.948 (0.483–1.86) .876 1.193 (0.792–1.797) .398 0.871 (0.559–1.357) .54
Dyslipidemia 1.319 (0.757–2.297) .328 — — 1.297 (0.865–1.945) .209 — —
Peripheral vascular disease 2.456 (1.48–4.078) .001 1.282 (0.696–2.363) .425 1.818 (1.228–2.69) .003 1.287 (0.83–1.995) .26
Smoker 0.806 (0.494–1.316) .39 — — 0.993 (0.692–1.424) .968 — —
COPD 2.851 (1.598–5.086) <.001 2.785 (1.483–5.23) .001 2.35 (1.49–3.707) <.001 2.143 (1.311–3.502) .002
Previous stroke 1.269 (0.509–3.164) .609 0.72 (0.272–1.906) .509 1.103 (0.538–2.26) .79 0.658 (0.308–1.303) .279
Chronic renal failure 2.843 (1.631–4.955) <.001 1.343 (0.699–2.580) .375 2.13 (1.37–3.313) .001 1.369 (0.829–2.258) .219
Previous AMI 0.967 (0.591–1.583) .894 — — 1.117 (0.778–1.602) .549 — —
Recent AMI (<90dd) 0.985 (0.584–1.66) .954 — — 1.117 (0.766–1.627) .565 — —
LVEF<50% 2.379 (1.447–3.911) .001 0.918 (0.483–1.763) .796 1.723 (1.177–2.522) .005 1.04 (0.66–1.64) .865
Severe pulmonary
hypertension*
6.336 (3.307–12.138) <.001 2.675 (1.293–5.536) .008 3.87 (2.174–6.888) <.001 2.34 (.246–4.396) .008
NYHA III/IV 3.701 (2.219–6.17) <.001 2.192 (1.266–3.796) .005 2.001 (1.396–2.869) <.001 1.503 (1.023–2.209) .038
Previous cardiac surgery 1.34 (0.43–4.274) .621 — — 0.923 (0.34–2.502) .875 — —
Critical preprocedural statey 4.206 (2.561–6.909) <.001 2.436 (1.422–4.173) .001 2.039 (1.354–3.07) .001 1.531 (0.993–2.36) .054
Incomplete revascularization 1.865 (1.106–3.145) .019 1.341 (0.754–2.384) .317 1.512 (1.043–2.191) .029 1.139 (0.757–1.714) .531
Saphenous graft 1.069 (0.645–1.771) .797 0.733 (0.393–1.369) .33 0.994 (0.688–1.435) .973 0.739 (0.494–1.104) .139
Radial artery graft 0.735 (0.331–1.639 .448 — — 0.71 (0.403–1.252) .237 — —
ITA graft 0.296 (0.041–2.153) .229 — — 0.198 (0.048–0.811) .024 0.236 (0.057–0.98) .047
Bilateral ITA graft 0.479 (0.218– 1.050) .066 1.371 (0.508–3.698) .533 0.694 (0.421–1.147) .201 — —
Coronary endarterectomy 1.752 (0.756–4.063) .191 1.909 (0.786–4.64) .153 1.506 (0.787–2.879) .216 1.552 (0.791–3.044) .201
Conversion to CPB 2.637 (1.342–5.181) .005 3.536 (1.688–7.407) .001 1.649 (0.908–2.996) .101 1,871 (1.002–3.493) .049
SYNTAX Score 1.054 (1.02–1.088) .001 1.046 (1.009–1.085) .015 1.037 (1.01–1.064) .007 1.034 (1.004–1.065) .026
Postprocedural and postdischarge MACCE included. Data expressed as HR and 95% CI. Univariate and multivariate binary logistic regression was performed. Variables to be
included in multivariate analysis: P<.2; and those associated with SYNTAX Score (P<.05). AMI, Acute myocardial infarction; MACCE, major adverse cardiac and cerebro-
vascular events. BMI, body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; HR, hazard ratio; ITA, internal thoracic artery;
CPB, cardiopulmonary bypass; NYHA, New York Heart Association; SYNTAX, SYNergy between percutaneous intervention with TAXus drug-eluting stents and cardiac surgery.
*Severe pulmonary hypertension: pulmonary systolic pressure>60mmHg. yCritical preprocedural state: ventricular tachycardia, ventricular fibrillation or aborted sudden death,
cardiac massage, invasive ventilatory support, need for inotropic support or balloon counterpulsation, acute renal failure (anuria or oliguria<10 mL/h).
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COPD, pulmonary systolic pressure greater than 60 mm
Hg, NYHA III/IV, conversion to CPB, and SYNTAX Score
were associated with a higher incidence of follow-up
MACCE, whereas internal thoracic artery grafting was as-
sociated with a lower rate. Once the balancing score was
added, SYNTAX Score remained associated with a higher
risk for late MACCE (HR, 1.034; 95% CI, 1.004–1.066;
P ¼ .027).
DISCUSSION
The SYNTAX study is a randomized, multicenter, non-
inferiority clinical trial that was designed to compare the
outcomes of PCI using drug-eluting stents and CABG to
treat 3-vessel and LMCA disease.6 The SYNTAX Score7
objectively assesses the technical difficulty of PCI such
that a higher score indicates more complex coronary
lesions.The Journal of Thoracic and CarThe validity of the SYNTAX Score within the trial itself
was recently examined by the trial’s researchers.8 After
a 1-year follow-up, no significant correlation was detected
between the SYNTAX Score and the incidence of MACCE
in the cohort of patients who underwent CABG surgery
(P ¼ .38). However, a significant link between SYNTAX
Score and MACCE (P ¼ .007) was observed in the PCI
group. Mohr and colleagues9 investigated whether the
SYNTAX Score affected CABG outcomes among the
1541 patients undergoing CABG included in the SYNTAX
trial and found no significant influence. In 2007, Valgimigli
and colleagues10 reported that in patients undergoing PCI,
the SYNTAX Score was able to better discriminate the in-
cidence of MACCE. In 2 recent studies addressing the im-
pact of the SYNTAX Score in patients undergoing coronary
surgery for LMCA13 and 3-vessel disease,14 results have not
been consistent. Birim and colleagues,13 in their study of
148 patients with LMCA disease who underwent surgery,diovascular Surgery c Volume 142, Number 3 e129
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free survival and showed excellent discriminatory power
(c-index 0.88). In contrast, Lemesle and colleagues14 found
no correlation between the SYNTAX Score (P ¼ .754) and
the incidence of MACCE in 320 patients with 3-vessel dis-
ease undergoing CABG. Serruys and colleagues12 reported
the impact of SYNTAX Score on clinical outcomes in 1205
patients from the ARTS-I trial and 607 patients from the
ARTS-II trial. They found that the SYNTAX Score was
an independent predictor (OR, 1.68; 95% CI, 1.22–2.28)
ofMACCE in a 5-year follow-up. Our study assessed the in-
fluence of the SYNTAX Score in a series of 716 patients
with 3-vessel or LMCA disease on the incidence of
MACCE during the postoperative course and follow-up of
CABG. For this purpose, we performed a multivariate anal-
ysis adjusted by a balancing score17 and found a significant
association between SYNTAX Score and early andmidterm
combined MACCE.
Another important issue that may explain the differences
between the present study and others is that surgical coro-
nary revascularization was performed off-pump in the ma-
jority of patients in the current study, whereas CABG was
performed on-pump in previous studies.9,12,13,14 Off-pump
CABG is more technically demanding than on-pump
CABG,18 and, in this scenario, a more complex coronary
disease may affect outcomes more directly and strongly.
The SYNTAX Score obtained in our cohort of patients
(mean, 34.5; SD, 6.7) is notably higher than that reported
by the authors of the SYNTAX trial (mean 29.1 in the
CABG group and 28.4 in the PCI group)8 or Birim and col-
leagues13 (mean, 24.9). This difference may be attributed to
several factors: (1) First, the creators of the SYNTAX Score
themselves warn of the system’s low interobserver
(weighted Kappa 0.45) and intraobserver (weighted Kappa
0.59) reproducibility.8 To minimize the error of low repro-
ducibility in our study, 2 observers interpreted the angio-
graphs of each patient. (2) In addition, patients
randomized in the SYNTAX trial had to be suitable for
the same completeness of both PCI and CABG revascular-
ization. Therefore, only patients who were less technically
demanding for PCI were selected for randomization.
Mohr and colleagues9 reported a mean SYNTAX Score of
29.1 (SD, 11.4) for those patients undergoing CABG who
were randomized in the SYNTAX trial and 37.8 (SD,
13.3) for those enrolled in the SYNTAX trial CABG regis-
try (similar to the mean score found in the present study).
This inclusion/selection bias makes it difficult to ascertain
whether the mean SYNTAX Score in the trial represents
that of the entire population with LMCA or 3-vessel dis-
ease. (3) Finally, most of our candidates for coronary sur-
gery had been previously rejected for a PCI procedure by
our center’s team of interventional cardiologists. All these
factors could explain the higher scores obtained in our pa-
tients. According to previous articles and this one, it ise130 The Journal of Thoracic and Cardiovascular Surhighly probable that the SYNTAX Score may predict out-
comes after CABG only for those patients with highly com-
plex coronary lesions, whereas it does not for thosewith low
or medium scores.13
The data reported in this article reveal a clear relation be-
tween the prevalence of cardiovascular risk factors and the
complexity and extent of coronary disease. Thus, when we
divided the SYNTAX Scores obtained into terciles, a higher
prevalence of peripheral arterial disease, diabetes, renal
failure, and stroke, and an older age were observed in the
2 top terciles (Table 1). In large population studies, such
as Framingham19 or INTERHEART,20 a higher prevalence
of cardiovascular risk factors has been linked to a greater
risk of cardiovascular events. It has also been reported
that the severity and extent of atherosclerotic lesions are re-
lated to the prevalence of risk factors.10,21-23 In the present
study, this relation has been observed once more. On the
other hand, previous studies13,14 failed to demonstrate this
fact. The reason for this could be that SYNTAX Scores
were considerably lower than those observed in our
population, meaning that those previous studies likely
included an insufficient number of patients with scores
high enough to detect such a relationship. We also noticed
a greater predicted risk (by euroSCORE scale) in the 2
top terciles (P< .001). A linear correlation was observed
between the SYNTAX Score and the euroSCORE
punctuations (b ¼ 0.152 euroSCORE points/SYNTAX
Score point, P<.001).
In the present study, the SYNTAX Score was indepen-
dently associated with postprocedural MACCE (P<.001,
OR ¼ 1.08), which was confirmed after adjustment by the
balancing score (P< .001, OR ¼ 1.065) (Table 4). This
link may be attributed to a greater mortality (P ¼ .011)
and incidence of AMI (P< .001) produced in the groups
of patients awarded the highest scores (Table 3). The rela-
tionship between higher SYNTAX Scores and poorer post-
operative outcomes were reported by Birim and
colleagues,13 who found this to be an independent predictor
of postoperative MACCE (relative risk, 1.2; 95% CI,
1.1–1.3). Although no statistically significant relation was
detected between in-hospital mortality and SYNTAX Score
(P¼ .077), we did observe a higher mortality among the pa-
tients showing the higher SYNTAX Scores (8.8% [score>
37] vs 3.2% [score 33–37] or 3.6% [score 33]). The high
incidence of myocardial infarction observed in the popula-
tion of this study might be explained by the definition we
used (see ‘‘Materials and Methods’’ section for events
definition).
In the follow-up (mean, 26.7 months; ranking, 0–62), we
found that patients with higher SYNTAX Scores had
a higher risk of death (P ¼ .008) and MACCE (P ¼ .009)
(Figure 1,A, B). On amultivariate analysis adjusted by a bal-
ancing score, SYNTAX Score was not independently asso-
ciated with mortality (HR, 1.029; P¼ .198), but it did showgery c September 2011
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P¼ .027). The SYNTAX investigators8 did not find a signif-
icant difference in the incidence of MACCE at 1 year
among the 3 terciles (22: 10.7%; 23–32: 11.7%; and
>33: 14.4%) of the CABG cohort in the SYNTAX study
(P ¼ .38). Lemesle and colleagues14 studied a cohort of
320 patients with 3-vessel disease undergoing CABG.
SYNTAX Score terciles were less than 24.5, 24.5 to 34,
and greater than 34. They did not find a significant differ-
ence in the composite event death/myocardial infarction/
stroke among the 3 groups at 1 year (P ¼ .754). To date,
only Birim and colleagues13 have reported the SYNTAX
Score as an independent predictor of MACCE at 1 year
(HR, 1.3; 95% CI, 1.1–1.2). We believe that other studies
have failed to prove the prognostic value of the SYNTAX
Score for outcomes in the follow-up for 3 possible reasons:
(1) the follow-up was not long enough, (2) events might be
more frequent in those with higher scores than reported in
these studies, or (3) the size of the sample was too small.
The SYNTAX Score was created in the setting of the
SYNTAX trial to help select a surgical or interventionist
therapeutic option based on the severity and extent of ath-
erosclerotic disease in patients with LMCA or 3-vessel
disease. Beyond the intended objectives, that trial and
others have demonstrated the relation between the SYN-
TAX Score and major adverse cardiac and cerebrovascular
events after PCI or CABG. This study provides objective
support for the intuitive idea that the severity and extent
of atherosclerotic coronary vessel damage will affect the
short and midterm outcomes of surgical coronary revascu-
larization.
LIMITATIONS
This retrospective study was conducted at a single center;
thus, the results may not be reproducible or consistent with
those of other studies. Although we precisely followed the
heart team decision algorithm provided by the SYNTAX in-
vestigators, retrospective SYNTAX Score assessment may
generate further bias. Future studies need to address the
mid- and long-term predictive and MACCE-discriminating
capacity of the SYNTAX Score in patients undergoing
CABG to corroborate the conclusions of this study.References
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